跳至主要内容
临床试验/NCT06510062
NCT06510062已完成1 期

Comparative Evaluation of Sustained Acoustic Medicine Device on Circulation

ZetrOZ, Inc.1 个研究点 分布在 1 个国家目标入组 67 人开始时间: 2024年7月22日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
1 期
状态
已完成
发起方
入组人数
67
试验地点
1
主要终点
Blood Flow (Perfusion Unit)

研究概览

简要总结

Comparative Evaluation of Sustained Acoustic Medicine Device on Circulation

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 50 Years(Adult)
性别
All
接受健康志愿者

入选标准

  • Healthy Volunteer

排除标准

  • Is pregnant/nursing
  • Has an active infection, open sores, or wounds in the treatment area
  • Has any preexisting extremity circulation condition

研究组 & 干预措施

SAM Ultrasound Device and Diclofenac Patch 1

Experimental

Patients receive treatment from the SAM Ultrasonic Diathermy Device 1 hour with 2.5% diclofenac ultrasound gel patch on right forearm. The SAM device emits continuous ultrasound at 3-megahertz (MHz) frequency and 0.132 watts/cm2 intensity.

干预措施: Sustained Acoustic Medicine (Device)

SAM Ultrasound Device and Diclofenac Patch 1

Experimental

Patients receive treatment from the SAM Ultrasonic Diathermy Device 1 hour with 2.5% diclofenac ultrasound gel patch on right forearm. The SAM device emits continuous ultrasound at 3-megahertz (MHz) frequency and 0.132 watts/cm2 intensity.

干预措施: 2.5% Diclofenac Patches (Drug)

SAM Ultrasound Device and Diclofenac Patch 2

Experimental

Patients receive treatment from the SAM Ultrasonic Diathermy Device 1 hour with 2.5% diclofenac ultrasound gel patch on left forearm. The SAM device emits continuous ultrasound at 3-megahertz (MHz) frequency and 0.132 watts/cm2 intensity.

干预措施: Sustained Acoustic Medicine (Device)

SAM Ultrasound Device and Diclofenac Patch 2

Experimental

Patients receive treatment from the SAM Ultrasonic Diathermy Device 1 hour with 2.5% diclofenac ultrasound gel patch on left forearm. The SAM device emits continuous ultrasound at 3-megahertz (MHz) frequency and 0.132 watts/cm2 intensity.

干预措施: 2.5% Diclofenac Patches (Drug)

SAM Ultrasound Device and SAM Patch 1

Experimental

Patients receive treatment from the SAM Ultrasonic Diathermy Device 1 hour with standard ultrasound gel patch on right forearm. The SAM device emits continuous ultrasound at 3-megahertz (MHz) frequency and 0.132 watts/cm2 intensity.

干预措施: Sustained Acoustic Medicine (Device)

SAM Ultrasound Device and SAM Patch 2

Experimental

Patients receive treatment from the SAM Ultrasonic Diathermy Device 1 hour with standard ultrasound gel patch on left forearm. The SAM device emits continuous ultrasound at 3-megahertz (MHz) frequency and 0.132 watts/cm2 intensity.

干预措施: Sustained Acoustic Medicine (Device)

结局指标

主要结局

Blood Flow (Perfusion Unit)

时间窗: 0 - 1 hour

Blood Flow Flux through Upper Extremity (Perfusion Unit)

Ultrasound Diathermy (Degrees Centigrade)

时间窗: 0 - 1 hour

Temperature Measurement on Body (Degrees Centrigrade)

次要结局

未报告次要终点

研究者

发起方
ZetrOZ, Inc.
申办方类型
Industry
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验